Skip to main content
ACHIEVE LIFE SCIENCES, INC. logo

ACHIEVE LIFE SCIENCES, INC. — Investor Relations & Filings

Ticker · ACHV ISIN · US0044685008 LEI · 549300V82ZKZDTAU0A46 US Manufacturing
Open in API
Filings indexed 1,014 across all filing types
Latest filing 2009-03-11 Annual Report
Country US United States of America
Listing US ACHV

About ACHIEVE LIFE SCIENCES, INC.

https://achievelifesciences.com/

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company dedicated to addressing the global nicotine dependence epidemic. The company's primary focus is the development and commercialization of its lead product candidate, cytisinicline, for smoking cessation. Following the successful completion of two Phase 3 studies, the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), which has been accepted for review. If approved, cytisinicline has the potential to become the first new FDA-approved treatment option for nicotine dependence in the United States in nearly two decades.

Recent filings

Filing Released Lang Actions
FORM 10-K
Annual Report FY 2008
2009-03-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text includes multiple items such as results of operations (Item 2.02), amendments to articles of incorporation (Item 5.03), adoption of a new code of ethics (Item 5.05), and disclosure of materials for a conference call (Item 7.01). The document references a press release of financial results and materials for a conference call but does not contain the full financial statements or detailed financial analysis itself. The presence of governance policy updates and corporate governance charters also indicates regulatory and governance disclosures. The document is not a full annual or quarterly report, nor is it a transcript or earnings release. It is a regulatory filing reporting various corporate events and disclosures. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (6279 characters) and content support this classification with high confidence.
2009-03-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on a temporary suspension of trading under the company's employee benefit plans due to a blackout period related to changes in the 401(k) Profit Sharing Plan. It includes notices sent to directors and executive officers and does not contain financial statements or detailed financial results. The document is about a regulatory event and employee plan update rather than a financial report or earnings release. Given the nature of the filing and the absence of financial data or management discussion, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2009-03-06 English
Board/Management Information 2009
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 12, 2009. It reports the termination of the company's 2006 Employee Stock Purchase Plan (ESPP) and mentions the departure of directors or officers. The content focuses on corporate governance changes and termination of a material definitive agreement. There are no financial statements or detailed financial data presented. The document is not an annual or quarterly report, nor an earnings release. It is primarily an announcement of management changes and termination of a plan. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 2543 characters, which is short and consistent with an 8-K filing announcing management and plan termination events.
2009-02-17 English
ONCOGENEX PHARMACEUTICALS LTD.
Major Shareholding Notification
2009-02-17 English
SCHEDULE 13G
Major Shareholding Notification
2009-02-13 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.